[ Editorials | Departments and Series | Index ]

 

Practice Algorithm


Hirsutism

Dan Israel Lebovic, MD, MA


Hirsutism affects up to 8% of women.1 It is defined as the presence of excessive terminal hair growth from androgen-dependent pilosebaceous units in regions of a woman’s body not usually associated with such hair growth. Hirsutism is a by-product of increased androgen action on hair follicles or increased sensitivity of hair follicles to normal levels of androgens. Although most etiologies are not life-threatening, hirsutism infrequently may herald more serious pathologies such as an androgen-producing neoplasm.

The possible causes of excess androgen production are myriad, including familial, idiopathic, ovarian (eg, tumors, polycystic ovary syndrome), and adrenal (eg, tumors, nonclassic congenital adrenal hyperplasia). Exogenous pharmacologic sources must be considered as well.

A thorough history and physical examination should evaluate amounts, characteristics, and distribution of hair growth; virilization (eg, deepening of the voice, pronounced acne) should also be noted. A pelvic examination—physical and/or via transvaginal ultrasonography—should be performed to exclude any masses. Limited laboratory testing may be required to rule out potentially serious underlying conditions (Figure).2,3

Click to enlarge

FIGURE. Evaluation of female sexual dysfunction.

dexa suppr = dexamethasone suppression; P4 = progesterone; 17 OHP = 17α hydroxyprogesterone; PCOS = polycystic ovary syndrome; NCAH = nonclassic congenital adrenal hyperplasia; ACTH = adrenocorticotropic hormone; TSH = thyroid-stimulating hormone; PRL = prolactin.

back to top


Dan Israel Lebovic, MD, MA, is associate professor and co-director, University of Michigan Endometriosis Center, Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, University of Michigan Hospitals, Ann Arbor.

References

  1. Carmina E, Rosato F, Janni A, Rizzo M, Longo RA. Extensive clinical experience: relative prevalence of different androgen excess disorders of 950 women referred because of clinical hyperandrogenism. J Clin Endocrinol Metab. 2006;91(1):2-6.
  2. Hunter MH, Carek PJ. Evaluation and treatment of women with hirsutism. Am Fam Physician. 2003;67(12):2565-2572.
  3. Rosenfield RL. Clinical practice. Hirsutism. N Engl J Med. 2005:353(24):2578-2588.

back to top


[ Home | CME/CE | Product News | Author Guidelines ]
[ Editorial Board | Reprints/Permissions | Archives | Circulation | Classifieds | Our Services ]


Copyright ©2000-2008 Quadrant HealthCom Inc., Parsippany, NJ, USA. All rights reserved. Unauthorized use prohibited. The information provided on femalepatient.com is for educational purposes only. Use of this Web site is subject to the medical disclaimer and privacy policy.